Skip to content

Insider · CIK 0001760582

Francis Duhay

director

Files at NVNO (enVVeno Medical Corp). First filing Jan 3, 2025, latest Sep 14, 2026.

In brief

Francis Duhay files SEC Form 4 as director at NVNO (enVVeno Medical Corp). Since Jan 3, 2025, Francis Duhay has reported 1 open-market buy worth $250k and 5 open-market sells worth $8,989, the latest filed on Sep 14, 2026.

A track record needs three past buys with six months of prices behind them; Francis Duhay has 0, so none is measured yet.

The newest scored trade: sold $123 of NVNO on Sep 11, 2026, filed Sep 14, 2026, scored 0 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $4,922.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 5
$250k bought, $8,989 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

NVNO: enVVeno Medical Corp

NVNOOct 9, 2026 · close 8.75

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
0Weak
NVNOsell10b5-1
enVVeno Medical Corp
$123
11 shares
-0%-
0Weak
NVNOsell10b5-1
enVVeno Medical Corp
$1,443
140 shares
-6%+18% from low-94% from high
0Weak
NVNOsell10b5-1
enVVeno Medical Corp
$1,613
140 shares
-5%+27% from low-94% from high
0Weak
NVNOsell10b5-1
enVVeno Medical Corp
$1,742
4,900 shares
-5%+11% from low-93% from high
0Weak
NVNOsell10b5-1
enVVeno Medical Corp
$4,067
4,900 shares
-5%+27% from low-83% from high
53Moderate
NVNObuy 5
enVVeno Medical Corp
$250k
81,433 shares
+389%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Sep 11, 2026 NVNO
enVVeno Medical Corp
11
0.00% of outstanding
$123Sep 11, 2026none
Jun 11, 2026 NVNO
enVVeno Medical Corp
140
0.02% of outstanding
$1,443Jun 11, 2026none
Mar 12, 2026 NVNO
enVVeno Medical Corp
140
0.00% of outstanding
$1,613Mar 12, 2026none
Sep 15, 2025 NVNO
enVVeno Medical Corp
9,800
0.05% of outstanding
$8,143Sep 15, 2025none

Transactions

Every row this insider has filed, 8 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 11, 2026NVNO
enVVeno Medical Corp
SOpen-market sale
Common Stock10b5-1
-11$11.21$1232,35129 d ago
Jun 11, 2026NVNO
enVVeno Medical Corp
SOpen-market sale
Common Stock10b5-1
-140$10.31$1,4432,362Jun 12, 2026
Mar 12, 2026NVNO
enVVeno Medical Corp
SOpen-market sale
Common Stock10b5-1
-140$11.52$1,6132,502Mar 13, 2026
Dec 11, 2025NVNO
enVVeno Medical Corp
AGrant or award
Stock Optionsderivative
+135,883$0.00$0135,883Dec 15, 2025
Dec 11, 2025NVNO
enVVeno Medical Corp
SOpen-market sale
Common Stock10b5-1
-4,900$0.36$1,74292,544Dec 12, 2025
Sep 15, 2025NVNO
enVVeno Medical Corp
SOpen-market sale
Common Stock10b5-1
-4,900$0.83$4,06797,444Sep 17, 2025
Dec 31, 2024NVNO
enVVeno Medical Corp
POpen-market purchase
Common Stock
+81,433$3.07$250k102,344Jan 3, 2025
Dec 18, 2024NVNO
enVVeno Medical Corp
AGrant or award
Stock Optionsderivative
+19,752$0.00$019,752Dec 20, 2024

Questions about Francis Duhay

Answered from the filings on this page, as of the latest one.

Is Francis Duhay buying or selling?

In the last 12 months Francis Duhay reported 0 open-market buys worth $0 and 4 open-market sells worth $4,922 on SEC Form 4; the latest was sold $123 of NVNO on Sep 11, 2026. Grants, option exercises and tax withholding are not counted.

How did Francis Duhay's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Francis Duhay has 0.

Where does Francis Duhay file Form 4?

Francis Duhay has filed Form 4 at NVNO (enVVeno Medical Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Francis Duhay: insider trades and track record | InsiderTell